Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

---

Neuroblastoma, one of the common malignant childhood tumors, arises from neuroblast cells derived from the
neural crest and destined for the adrenal medulla and the sympathetic nervous system and shows remarkable biological
heterogeneity, resulting in favorable or unfavorable outcomes. Some tumors make rapid progress with a fatal
outcome. In other instances, the tumors regress spontaneously in infants or to differentiate into a benign ganglioneuroma
in older patients. This heterogeneity within neuroblastoma depends on the molecular characteristics of tumor
cells. Several distinct genomic alterations have been found in neuroblastoma, including MYCN amplification, DNA
ploidy, deletion of the short arm of chromosome 1, gain of chromosome 17q, and deletion of 11q. The difference of
expression was also found in genes related to cellular growth, differentiation, and apoptosis of neural network including
signaling by NTRK1 or ALK receptor tyrosine kinases, and telomerase activity. And this presentation discusses
diagnostic and prognostic molecular makers for extensive heterogeneity of neuroblastoma. This should lead to more
risk-adapted therapies according to the genetic markers by which individual neuroblastomas are biologically characterized.

Keywords: Neuroblastoma, Prognosis, MYCN, Ploidy, Chromosome, Telomerase, Telomere, Apoptosis

Full-Text [PDF 2803 kb]   (4727 Downloads)    

Add your comments about this article : Your username or Email:

---